News

Happy Wednesday! Top-tier tech colleges and B-schools are becoming more invested in their tots’ startup dreams. This and more ...
Q2 2025 Management View Evan T. Spiegel, CEO, highlighted Snap's progress on its long-term strategy, citing "932 million ...
Day One Biopharmaceuticals reports strong Q2 2025 growth for OJEMDA, sets $140M-$150M full-year revenue guidance, and advances its pipeline.
Key Points EPS (Non-GAAP) of $1.13 beat the analyst estimate of $0.73 for Q2 2025, exceeding forecasts by 54.8% on a non-GAAP basis. Revenue (GAAP) was $194.5 million, surpassing expectations, with ...
Track top stocks like Bharti Airtel, Lupin, and NSDL today as earnings and key IPOs drive market action-see which stocks ...
The RBI MPC is expected to hold the repo rate steady today after three consecutive cuts, opting for a ‘dovish pause’ amid ...
Guidance for Q1 fiscal 2026 and the full year shifted from a cautious approach in Q3 to explicit targets of $6–$7 billion for Q1 and at least $33 billion for the full year. Previous quarter guidance ...